Showing 1 - 10 of 17
This paper examines whether the composition of medical research responds to changes in disease incidence and research opportunities. The paper also provides new evidence on induced pharmaceutical innovation. In both cases we use the change in the demographic structure of the market (measured by...
Persistent link: https://www.econbiz.de/10012464785
This paper examines whether the composition of medical research responds to changes in disease incidence and research opportunities. The paper also provides new evidence on induced pharmaceutical innovation. In both cases we use the change in the demographic structure of the market (measured by...
Persistent link: https://www.econbiz.de/10012750249
Persistent link: https://www.econbiz.de/10001905007
The aim of this article is to analyze the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: Minimum Efficacy Standards (MES) and Price Controls (PC). We develop a model of adverse selection where a...
Persistent link: https://www.econbiz.de/10014212001
Throughout history, technological progress has transformed population health, but the distributional effects of these gains are unclear. New substitutes for older, more expensive health technologies can produce convergence in population health outcomes, but may also be prone to "elite capture"...
Persistent link: https://www.econbiz.de/10014104950
Throughout history, technological progress has transformed population health, but the distributional effects of these gains are unclear. New substitutes for older, more expensive health technologies can produce convergence in population health outcomes, but may also be prone to “elite...
Persistent link: https://www.econbiz.de/10012893126
This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: Minimum Efficacy Standards (MES) and a mix of Minimum Efficacy Standards and Price Controls mechanisms (MES PC). Through a...
Persistent link: https://www.econbiz.de/10013114471
Persistent link: https://www.econbiz.de/10003792349
Persistent link: https://www.econbiz.de/10003852323
The support for scientific investigation in biomedicine depends in part on the adoption of new knowledge into medical practice. We investigate how a technological advance, in the form of a large and influential 2010 randomized controlled study, changed physician practice in statin (a medication...
Persistent link: https://www.econbiz.de/10012863696